For example, pharmaceutical companies have insisted that the TPP force all countries to grant 12-year patents on prescription drugs – increasing their profits while delaying competition from cheaper generic versions. Likewise, tobacco companies are seeking to use the TPP to prohibit developing countries – which represent the largest cigarette markets – from adopting new controls on their products.